Xie C - Search Results

1

Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of ⁶⁸Ga-Labeled FAPI Dimer.

Zhao L, Niu B, Fang J, Pang Y, Li S, Xie C, Sun L, Zhang X, Guo Z, Lin Q, Chen H. Zhao L, et al. Among authors: xie c. J Nucl Med. 2022 Jun;63(6):862-868. doi: 10.2967/jnumed.121.263016. Epub 2021 Sep 23. J Nucl Med. 2022. PMID: 34556528 Free PMC article.

2

Differential diagnostic value of ¹⁸F-FDG PET/CT for benign and malignant vertebral compression fractures: comparison with magnetic resonance imaging.

He X, Zhao L, Guo X, Zhao L, Wu J, Huang J, Sun L, Xie C, Chen H. He X, et al. Among authors: xie c. Cancer Manag Res. 2018 Jul 18;10:2105-2115. doi: 10.2147/CMAR.S168374. eCollection 2018. Cancer Manag Res. 2018. PMID: 30050321 Free PMC article.

3

Comparison of [⁶⁸Ga]Ga-DOTA-FAPI-04 and [¹⁸F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer.

Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, Wei J, Wu S, Zhao L, Luo Z, Lin X, Xie C, Sun L, Lin Q, Wu H. Chen H, et al. Among authors: xie c. Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1820-1832. doi: 10.1007/s00259-020-04769-z. Epub 2020 Mar 28. Eur J Nucl Med Mol Imaging. 2020. PMID: 32222810

4

Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [⁶⁸Ga]Ga-FAPI-04 PET/CT versus MRI and [¹⁸F]-FDG PET/CT.

Guo W, Pang Y, Yao L, Zhao L, Fan C, Ke J, Guo P, Hao B, Fu H, Xie C, Lin Q, Wu H, Sun L, Chen H. Guo W, et al. Among authors: xie c. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1604-1617. doi: 10.1007/s00259-020-05095-0. Epub 2020 Nov 11. Eur J Nucl Med Mol Imaging. 2021. PMID: 33179149

5

As a downstream target of the AKT pathway, NPTX1 inhibits proliferation and promotes apoptosis in hepatocellular carcinoma.

Zhao Y, Yu Y, Zhao W, You S, Feng M, Xie C, Chi X, Zhang Y, Wang X. Zhao Y, et al. Among authors: xie c. Biosci Rep. 2019 Jun 4;39(6):BSR20181662. doi: 10.1042/BSR20181662. Print 2019 Jun 28. Biosci Rep. 2019. PMID: 31113871 Free PMC article.

6

Ubiquitin-specific protease 11 serves as a marker of poor prognosis and promotes metastasis in hepatocellular carcinoma.

Zhang S, Xie C, Li H, Zhang K, Li J, Wang X, Yin Z. Zhang S, et al. Among authors: xie c. Lab Invest. 2018 Jul;98(7):883-894. doi: 10.1038/s41374-018-0050-7. Epub 2018 Mar 15. Lab Invest. 2018. PMID: 29545598 Free article.

7

Overexpression and clinical relevance of the RNA helicase DHX15 in hepatocellular carcinoma.

Xie C, Liao H, Zhang C, Zhang S. Xie C, et al. Hum Pathol. 2019 Feb;84:213-220. doi: 10.1016/j.humpath.2018.10.006. Epub 2018 Oct 17. Hum Pathol. 2019. PMID: 30339968

8

Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma.

Xie CR, Sun HG, Sun Y, Zhao WX, Zhang S, Wang XM, Yin ZY. Xie CR, et al. Mol Med Rep. 2015 Sep;12(3):4203-4209. doi: 10.3892/mmr.2015.3970. Epub 2015 Jun 22. Mol Med Rep. 2015. PMID: 26095787 Free PMC article.

9

Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma.

Xie CR, Li Z, Sun HG, Wang FQ, Sun Y, Zhao WX, Zhang S, Zhao WX, Wang XM, Yin ZY. Xie CR, et al. Oncotarget. 2015 Dec 1;6(38):40940-52. doi: 10.18632/oncotarget.5724. Oncotarget. 2015. PMID: 26517514 Free PMC article.

10

Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7.

Ji P, Liang S, Li P, Xie C, Li J, Zhang K, Zheng X, Feng M, Li Q, Jiao H, Chi X, Zhao W, Zhang S, Wang X. Ji P, et al. Among authors: xie c. Biochem Biophys Res Commun. 2018 Jul 7;502(1):30-42. doi: 10.1016/j.bbrc.2018.05.115. Epub 2018 May 24. Biochem Biophys Res Commun. 2018. PMID: 29777712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,629 results

Search Page